Cristina Rabascio Selected Research

Cristina Rabascio Research Topics

Disease

11	Neoplasms (Cancer) 01/2017 - 09/2003
4	Breast Neoplasms (Breast Cancer) 01/2017 - 09/2004
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2015 - 12/2009
2	Hematologic Neoplasms (Hematological Malignancy) 08/2012 - 06/2004
2	Lymphoma (Lymphomas) 02/2012 - 12/2010
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2012 - 06/2002
2	Vascular Remodeling 10/2010 - 01/2008
2	Colorectal Neoplasms (Colorectal Cancer) 10/2010 - 09/2003
2	Neoplasm Metastasis (Metastasis) 05/2010 - 09/2004
1	Infections 09/2012
1	Autoimmune Diseases (Autoimmune Disease) 09/2012
1	Bronchiolitis Obliterans Syndrome 09/2012
1	Hodgkin Disease (Hodgkin's Disease) 02/2012
1	Multiple Myeloma 02/2012
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2010
1	Cardiotoxicity 05/2010
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 05/2010
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2008
1	Leukemia 11/2008
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2008
1	Hypoxia (Hypoxemia) 01/2008

Drug/Important Bio-Agent (IBA)

3	Bevacizumab (Avastin)FDA Link 06/2015 - 09/2003
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2012 - 09/2004
3	Pharmaceutical PreparationsIBA 09/2011 - 11/2008
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 09/2012
2	Capecitabine (Xeloda)FDA Link 06/2015 - 12/2009
2	Filgrastim (Neupogen)FDA Link 02/2012 - 12/2010
2	Cell-Free Nucleic AcidsIBA 10/2010 - 06/2004
2	RNA (Ribonucleic Acid)IBA 10/2010 - 06/2004
2	Rituximab (Mabthera)FDA Link 08/2010 - 05/2010
2	Cladribine FDA LinkGeneric 08/2010 - 05/2010
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2010 - 12/2009
2	Angiogenesis InhibitorsIBA 05/2010 - 09/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2004 - 09/2003
1	Metalloproteases (Metalloproteinases)IBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2015
1	Tyrosine Kinase InhibitorsIBA 10/2015
1	Vinorelbine (Navelbine)FDA LinkGeneric 06/2015
1	Viral ProteinsIBA 09/2012
1	Immunoglobulin G (IgG)IBA 09/2012
1	AntibodiesIBA 09/2012
1	Biosimilar PharmaceuticalsIBA 02/2012
1	plerixafor FDA Link 02/2012
1	Sunitinib (Sutent)FDA Link 09/2011
1	pegfilgrastim (Neulasta)FDA Link 12/2010
1	Biological ProductsIBA 05/2010
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2009
1	Imatinib Mesylate (Gleevec)FDA Link 12/2009
1	Biomarkers (Surrogate Marker)IBA 01/2008
1	SERPIN-B5 (maspin)IBA 09/2004
1	Keratins (Keratin)IBA 09/2004
1	Indicators and Reagents (Reagents)IBA 09/2004
1	cadherin 5IBA 06/2004
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2004
1	Monoclonal AntibodiesIBA 06/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 06/2015 - 09/2004
4	Therapeutics 06/2015 - 11/2008
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2012
1	Colectomy 10/2010
1	Transplantation 11/2008
1	Blood Component Removal (Apheresis) 09/2004
1	Autologous Transplantation 09/2004